Celine Foote1, Philip A Clayton2, David W Johnson3, Meg Jardine4, Paul Snelling5, Alan Cass6. 1. The George Institute for Global Health, The University of Sydney, Sydney, Australia; Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: cfoote@georgeinstitute.org.au. 2. Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; Australian and New Zealand Dialysis and Transplant Registry (ANZDATA), Adelaide, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. 3. Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia. 4. The George Institute for Global Health, The University of Sydney, Sydney, Australia; Department of Nephrology, Concord Repatriation General Hospital, Sydney, Australia. 5. Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia. 6. The George Institute for Global Health, The University of Sydney, Sydney, Australia; Menzies School of Health Research, Darwin, Australia.
Abstract
BACKGROUND: Late referral for renal replacement therapy (RRT) leads to worse outcomes. In 2005, estimated glomerular filtration rate (eGFR) reporting began in Australasia, with an aim of substantially increasing earlier disease detection. STUDY DESIGN: Observational cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) data. SETTING & PARTICIPANTS: All patients commencing RRT in Australasia between January 1, 1999, and December 31, 2010. We excluded the period between December 31, 2004, and January 1, 2007, to allow for practice change. FACTOR: Introduction of eGFR reporting. OUTCOMES: Primary outcome was late referral defined as commencing RRT within 3 months of nephrology referral. Secondary outcomes included initial RRT modality and prepared access at hemodialysis therapy initiation. MEASUREMENTS: Late referral rates per era were determined and multilevel logistic regression was used to identify late referral predictors. RESULTS: We included 25,009 patients. Overall, 3,433 (25.3%) patients were referred late in the pre-eGFR era compared with 2,464 (21.6%) in the post-eGFR era, for an absolute reduction of 3.7% (95% CI, 2.7%-4.8%; P<0.001). After adjustments for age, body mass index, race, comorbid conditions, and primary kidney disease, adjusted late referral rates were 25.8% (95% CI, 23.3%-28.3%) and 21.8% (95% CI, 19.2%-24.4%) in the pre- and post-eGFR eras, respectively, for a difference of 4.0% (95% CI, 1.2%-6.8%; P=0.005). Late referral risk was attenuated significantly post-eGFR reporting (OR, 1.30; 95% CI, 1.12-1.51) compared to pre-eGFR reporting (OR, 2.15; 95% CI, 1.88-2.46) for indigenous patients. Late referral rates decreased for older patients but increased slightly for younger patients (P=0.001 for interaction between age and era). There was no impact on initial RRT modality or prepared access rates at hemodialysis therapy initiation between eras. LIMITATIONS: Residual confounding could not be excluded. CONCLUSIONS: eGFR reporting was associated with small reductions in late referral, but more than 1 in 5 patients are still referred late. Other initiatives to increase timely referral warrant investigation.
BACKGROUND: Late referral for renal replacement therapy (RRT) leads to worse outcomes. In 2005, estimated glomerular filtration rate (eGFR) reporting began in Australasia, with an aim of substantially increasing earlier disease detection. STUDY DESIGN: Observational cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) data. SETTING & PARTICIPANTS: All patients commencing RRT in Australasia between January 1, 1999, and December 31, 2010. We excluded the period between December 31, 2004, and January 1, 2007, to allow for practice change. FACTOR: Introduction of eGFR reporting. OUTCOMES: Primary outcome was late referral defined as commencing RRT within 3 months of nephrology referral. Secondary outcomes included initial RRT modality and prepared access at hemodialysis therapy initiation. MEASUREMENTS: Late referral rates per era were determined and multilevel logistic regression was used to identify late referral predictors. RESULTS: We included 25,009 patients. Overall, 3,433 (25.3%) patients were referred late in the pre-eGFR era compared with 2,464 (21.6%) in the post-eGFR era, for an absolute reduction of 3.7% (95% CI, 2.7%-4.8%; P<0.001). After adjustments for age, body mass index, race, comorbid conditions, and primary kidney disease, adjusted late referral rates were 25.8% (95% CI, 23.3%-28.3%) and 21.8% (95% CI, 19.2%-24.4%) in the pre- and post-eGFR eras, respectively, for a difference of 4.0% (95% CI, 1.2%-6.8%; P=0.005). Late referral risk was attenuated significantly post-eGFR reporting (OR, 1.30; 95% CI, 1.12-1.51) compared to pre-eGFR reporting (OR, 2.15; 95% CI, 1.88-2.46) for indigenous patients. Late referral rates decreased for older patients but increased slightly for younger patients (P=0.001 for interaction between age and era). There was no impact on initial RRT modality or prepared access rates at hemodialysis therapy initiation between eras. LIMITATIONS: Residual confounding could not be excluded. CONCLUSIONS: eGFR reporting was associated with small reductions in late referral, but more than 1 in 5 patients are still referred late. Other initiatives to increase timely referral warrant investigation.
Authors: Oskar Swartling; Yuanhang Yang; Catherine M Clase; Edouard L Fu; Manfred Hecking; Sebastian Hödlmoser; Ylva Trolle-Lagerros; Marie Evans; Juan J Carrero Journal: J Am Soc Nephrol Date: 2022-07-29 Impact factor: 14.978
Authors: Htay Htay; David W Johnson; Jonathan C Craig; Armando Teixeira-Pinto; Carmel M Hawley; Yeoungjee Cho Journal: Cochrane Database Syst Rev Date: 2021-01-27
Authors: Htay Htay; David W Johnson; Jonathan C Craig; Armando Teixeira-Pinto; Carmel M Hawley; Yeoungjee Cho Journal: Cochrane Database Syst Rev Date: 2020-12-15
Authors: Seon Ha Baek; Shin young Ahn; Sung Woo Lee; Youn Su Park; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Suhnggwon Kim; Ho Jun Chin Journal: PLoS One Date: 2015-06-01 Impact factor: 3.240
Authors: Christy C Chong; Helen Tam-Tham; Brenda R Hemmelgarn; Robert G Weaver; Nairne Scott-Douglas; Marcello Tonelli; Robert R Quinn; Liam Manns; Braden J Manns Journal: Can J Kidney Health Dis Date: 2017-03-22